EVO · NASDAQ
Evotec SE (EVO) Stock Price & Fundamentals
$868.58−0.19%−$1.68End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Evotec SE (EVO) closed at $868.58 on Oct 9, 2026, down 0.19% from the previous close of $870.26.
Share price, past year
1Y −7.50%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $868.58 |
| Sep 30, 2026 | $863.21 |
| Aug 31, 2026 | $944.08 |
| Jul 31, 2026 | $957.08 |
| Jun 30, 2026 | $931.51 |
| May 29, 2026 | $885.05 |
| Apr 30, 2026 | $967.40 |
| Mar 31, 2026 | $1,021.62 |
| Feb 27, 2026 | $996.72 |
| Jan 30, 2026 | $1,018.29 |
| Dec 31, 2025 | $1,047.61 |
| Nov 28, 2025 | $1,021.72 |
| Oct 31, 2025 | $986.11 |
Key statistics
- 52-week range
- $854.57 – $1,061.94
Financials
Evotec SE reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Evotec SE
- Ticker
- EVO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Essener Bogen 7, Hamburg, 22419
- Incorporated in
- 2M
- Fiscal year ends
- December
- SEC CIK
- 0001412558
Frequently asked questions
What is Evotec SE's stock price?
Evotec SE (EVO) closed at $868.58 on Oct 9, 2026, down 0.19% from the previous close of $870.26.
Sources and methodology
Fundamentals come from Evotec SE's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures